Investors in cash trouble should check out Liquidia Corp (LQDA)

With 0.91 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.59 whereas the lowest price it dropped to was $7.36. The 52-week range on LQDA shows that it touched its highest point at $9.95 and its lowest point at $5.67 during that stretch. It currently has a 1-year price target of $14.00. Beta for the stock currently stands at -0.11.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LQDA was up-trending over the past week, with a rise of 4.26%, but this was up by 18.30% over a month. Three-month performance surged to 15.20% while six-month performance fell -17.60%. The stock gained 20.79% in the past year, while it has gained 17.19% so far this year. A look at the trailing 12-month EPS for LQDA yields -0.89 with Next year EPS estimates of -1.16. For the next quarter, that number is -0.24. This implies an EPS growth rate of -53.55% for this year and -13.03% for next year.


Float and Shares Shorts:

At present, 64.52 million LQDA shares are outstanding with a float of 55.89 million shares on hand for trading. On Nov 29, 2023, short shares totaled 4.18 million, which was 6.44% higher than short shares on Oct 30, 2023. In addition to Dr. Roger A. Jeffs Ph.D. as the firm’s CEO & Director, Mr. Michael Kaseta serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 48.19% of LQDA’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 53.77% of LQDA, in contrast to 35.16% held by mutual funds. Shares owned by individuals account for 10.95%. As the largest shareholder in LQDA with 15.96% of the stake, Caligan Partners LP holds 10,360,945 shares worth 10,360,945. A second-largest stockholder of LQDA, BlackRock Fund Advisors, holds 2,970,652 shares, controlling over 4.58% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in LQDA, holding 2,690,618 shares or 4.14% stake. With a 2.36% stake in LQDA, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 1,531,173 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 1.79% of LQDA stock, is the second-largest Mutual Fund holder. It holds 1,160,028 shares valued at 8.31 million. Vanguard Extended Market Index Fu holds 1.15% of the stake in LQDA, owning 744,401 shares worth 5.33 million.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LQDA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With LQDA analysts setting a high price target of $18.00 and a low target of $3.00, the average target price over the next 12 months is $14.00. Based on these targets, LQDA could surge 140.96% to reach the target high and fall by -59.84% to reach the target low. Reaching the average price target will result in a growth of 87.42% from current levels.

Summary of Insider Activity:

Insiders traded LQDA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 22 while that of sell transactions has risen to 8 over the past year. The total number of shares bought during that period was 860,651 while 7,014 shares were sold.